Eli Lilly Pledges $15M To Infectious Disease Research Institute To Continue Lilly TB Drug Discovery Initiative

GeekWire: Eli Lilly commits $15 million to fund TB drug discovery through Seattle-based initiative
“The Seattle-based Infectious Disease Research Institute (IDRI), a product-focused nonprofit that fights infectious diseases around the world, announced [Thursday] that it will receive $15 million from pharmaceutical giant Eli Lilly to continue its work in developing drugs to treat tuberculosis. … The newest commitment is a continuation of the Lilly TB Drug Discovery Initiative, a public-private partnership between the two organizations founded in 2007 and headquartered in Seattle…” (McGrane, 11/3).